Sustained dopaminergic response of parkinsonism and depression in POLG-associated parkinsonism.
Synofzik
Matthis
M
Asmus
Friedrich
F
Reimold
Matthias
M
Schöls
Ludger
L
Berg
Daniela
D
D000339:Affect / Q000187:drug effects*; D000074002:DNA Polymerase gamma; D004259:DNA-Directed DNA Polymerase / Q000378:metabolism*; D003863:Depression / Q000188:drug therapy* / Q000209:etiology; D015259:Dopamine Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007211:Indoles / Q000627:therapeutic use; D007980:Levodopa / Q000627:therapeutic use; D008875:Middle Aged; D020734:Parkinsonian Disorders / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000378:metabolism / Q000523:psychology; D011877:Radionuclide Imaging; D016896:Treatment Outcome
D015259:Dopamine Agents; D007211:Indoles; C046649:ropinirole; D007980:Levodopa; D000074002:DNA Polymerase gamma; D004259:DNA-Directed DNA Polymerase; C413027:POLG protein, human